A retrospective analysis of survival prognostic factors and risk stratification in recurrent glioblastoma
We developed and internally validated a nomogram-based risk stratification model for rGBM. By integrating key clinical and molecular factors, this tool accurately predicts patient survival.
Authors
- Han Wu (ORCID: https://orcid.org/0000-0002-7418-2930)
- Lei She (ORCID: https://orcid.org/0000-0002-0930-871X)
- Xin Zhang (ORCID: https://orcid.org/0000-0001-7844-593X)
- Lin Su (ORCID: https://orcid.org/0000-0002-6458-4610)
- Chunxiong Zheng (ORCID: https://orcid.org/0000-0001-5735-633X)
Institutions
- Central South University (CN)
- National Clinical Research (US)
- Chenzhou First People's Hospital (CN)
- Xiangya Hospital Central South University (CN)
- Xiangnan University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1080/07853890.2025.2533435
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00